Purchases and Sales Made in Q4 2022 in Paratek Pharmaceuticals, Inc. (PRTK)
This table provides information about the institutional ownership of Paratek Pharmaceuticals, Inc. (PRTK) during Q4 2022. The information is specifically focused on institutions that hold shares of Paratek Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
General American Investors CO Inc
|
SELL
|
- |
-31.7K- 1.65% |
$52.9K - $79.6K
|
1.88M
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Mario Gabelli
Gamco Investors, Inc. Et Al | Rye, Ny
|
SELL
|
- |
-34K- 68.69% |
$56.8K - $85.3K
|
15.5K
$0
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-52.3K- 67.24% |
$87.4K - $131K
|
25.5K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-52.3K- 67.24% |
$87.4K - $131K
|
25.5K
$0
|
|
|
Feb 09, 2023
Q4 2022
|
Cm Management, LLC
|
SELL
|
- |
-55K- 13.75% |
$91.9K - $138K
|
345K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-56K- 28.45% |
$93.4K - $140K
|
141K
$0
|
|
|
Feb 09, 2023
Q4 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-63.1K- 61.26% |
$105K - $158K
|
39.9K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-82.3K- 75.58% |
$137K - $207K
|
26.6K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-82.5K- 18.69% |
$138K - $207K
|
359K
$0
|
|
|
Jan 12, 2023
Q4 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-83.1K- 38.78% |
$139K - $209K
|
131K
$0
|
|
|
Feb 02, 2023
Q4 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-243K- 93.92% |
$405K - $609K
|
15.7K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-284K- 93.62% |
$474K - $713K
|
19.4K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-409K- 89.03% |
$682K - $1.03M
|
50.4K
$0
|